YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
U.S. regulators approved the first new treatment for Alzheimer's disease in nearly 20 years.
Biogen Inc.'s aducanumab medication is designed to target the underlying cause of Alzheimer's.
Scientists reportedly are divided over the treatment's potential impact due to uncertain trial results.
Read more from BBC News.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach